Remove 2009 Remove Communication Remove Pharmaceutical Companies
article thumbnail

Health Innovators: Graeme Duncan, Advanz Pharma

pharmaphorum

In this episode of our Health Innovators series, Paul Tunnah interviews Graeme Duncan, CEO of specialty pharmaceutical company Advanz Pharma. Graeme discusses his career in the life sciences industry and how Advanz Pharma positions itself as the go-to partner for companies commercialising complex medicines in Europe.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceutical companies. Article 63 EMA (29 January 2020).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Alexion’s Camilla Harder Hartvig on making the impossible possible in rare disease

pharmaphorum

Online communication now seems the natural way to get things done, and the sky’s the limit for what we can achieve for our rare disease patients if we continue to drive this innovation and this openness.”. Connect with Dr Tunnah at [link] or [link].

Hospitals 111
article thumbnail

Why pharma needs a revolution in culture

pharmaphorum

He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.” As the sector looks to maintain its momentum, it must be wary that positive messaging and increased scrutiny does not end up as a recipe for a hard fall.

article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

article thumbnail

The calm after the storm: How COVID-19 is making pharma more resilient

pharmaphorum

Since the start of the year, pharmaceutical companies have been riding a rollercoaster of challenges. As the industry moves from a face-to-face to digital communication model, it needs a change of mindset, he adds. “A Pawlu describes a “perfect storm” as the various strands came together to threaten supply chains.

article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

So, this was back in 2009, and I hosted a Halloween party at my house, and I decided to dress up as Hunter S. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. So, I didn’t look so bad.